4D PHARMA PLC (DDDD)

4D PHARMA PLC (DDDD)

Blog posts

Financial Ombudsman and FCA considered lacking, plus defective Insolvency Regime

The views expressed in this article are those of its author and not necessarily those of ShareSoc. The stock markets are in turmoil now everyone is back from their holidays and facing up to the realisation that with high inflation and looming recessions the stock market may not be the best place to be for investors. I have moved more into cash and more defensive shares but cash is not the place to be for very long when inflation is eroding its ...

Laggard DDDD – 4D Pharma placing with no Primary Bid individual offer

By Cliff Weight, ShareSoc Director. I hold shares in DDDD. I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy. The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%. However ...

A Review of my Portfolio in 2020

By Cliff Weight, ShareSoc Director Please note I am not qualified to give investment advice, and nothing in this blog constitutes advice. Overview Chris Spencer Phillips reported in a recent blog https://www.sharesoc.org/blog/investment-strategies/a-review-of-my-2020-share-portfolio-chris-spencer-phillips/ that his portfolio was up +80% in 2020, after being + 25% in 2019. Congrats and hats off to Chris. I cannot rival that, but I thought readers might find my review of 2020 of interest. My portfolio numbers for 2020 were: Everything – all equities, ISAs, SIPPs, OEICS, etc       ...

Leaders and Laggards

Laggard DDDD – 4D Pharma placing with no Primary Bid individual offer

By Cliff Weight, ShareSoc Director. I hold shares in DDDD. I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy. The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%. However ...